Detalles de la búsqueda
1.
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial.
Clin Gastroenterol Hepatol
; 20(9): 2074-2082, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843987
2.
Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study.
Clin Gastroenterol Hepatol
; 20(4): 787-797.e2, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359726
3.
How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patients.
Scand J Gastroenterol
; 57(11): 1312-1320, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722732
4.
Predictors of each quality of life dimension in Crohn's disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristics.
Scand J Gastroenterol
; 57(5): 566-573, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35188859
5.
Usefulness of confocal laser endomicroscopy for predicting postoperative recurrence in patients with Crohn's disease: a pilot study.
Gastrointest Endosc
; 90(1): 151-157, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30849396
6.
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.
Gut
; 67(1): 53-60, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28119352
7.
Interstitial Nephritis Secondary to Vedolizumab Treatment in Crohn Disease and Safe Rechallenge Using Steroids: A Case Report.
Am J Kidney Dis
; 71(1): 142-145, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29162338
8.
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
Gastroenterology
; 142(1): 63-70.e5; quiz e31, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21945953
9.
Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif.
Clin Transl Gastroenterol
; 14(12): e00607, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37523417
10.
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(3): 215-227, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36640794
11.
Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model.
Clin Pharmacokinet
; 61(1): 143-154, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351609
12.
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.
Inflamm Bowel Dis
; 28(8): 1198-1206, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636895
13.
Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment-A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model.
Pharmaceutics
; 13(11)2021 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34834236
14.
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.
Aliment Pharmacol Ther
; 54(3): 312-319, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34151448
15.
A robust estimation of infliximab pharmacokinetic parameters in Crohn's disease.
Eur J Clin Pharmacol
; 71(12): 1541-2, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26369535
16.
Hypercontractile esophagus resolved after radiofrequency catheter ablation for atrial fibrillation: About a case.
Neurogastroenterol Motil
; 32(11): e13886, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32483908
17.
Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration.
Clin Pharmacokinet
; 57(9): 1173-1184, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29236229
18.
Successful autologous stem cell transplantation in Gaucher disease patient with multiple myeloma.
Am J Hematol
; 86(6): 529-30, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21509799
19.
The underlying inflammatory chronic disease influences infliximab pharmacokinetics.
MAbs
; 8(7): 1407-1416, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27589009
20.
Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's Disease.
Clin Pharmacokinet
; 54(5): 551-62, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25516415